Prestige Consumer Healthcare Inc.
PBH- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001295947
No open-market purchases or sales by Prestige Consumer Healthcare Inc. insiders were filed in the last 90 days; 319 institutions reported holding it in 13F filings for Q2 2026, worth $2.54B in total; Maverick Capital is the only superinvestor holding it.
13F holders, Q4 2023
Institutional positions in Prestige Consumer Healthcare Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 288
- +11 vs. Q3 2023
- Shares held
- 51.1M
- +212.8K (+0.4%) vs. Q3 2023
- Total value
- $3.13B
- +$216.1M (+7.4%) vs. Q3 2023
- New holders
- 36
- 96 more added
- Sold out
- 25
- 108 more reduced
3 institutions that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PBH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 319 | $2.54B |
| Q1 2026 | 354 | $3.08B |
| Q4 2025 | 354 | $3.18B |
| Q3 2025 | 356 | $3.17B |
| Q2 2025 | 377 | $4.16B |
| Q1 2025 | 358 | $4.44B |
| Q4 2024 | 337 | $4.10B |
| Q3 2024 | 327 | $3.68B |
| Q2 2024 | 305 | $3.51B |
| Q1 2024 | 312 | $3.72B |
| Q4 2023 | 288 | $3.13B |
| Q3 2023 | 280 | $2.91B |
| Q2 2023 | 278 | $2.97B |
| Q1 2023 | 283 | $3.16B |
| Q4 2022 | 288 | $3.13B |
| Q3 2022 | 276 | $2.49B |
| Q2 2022 | 285 | $2.98B |
| Q1 2022 | 286 | $2.67B |
| Q4 2021 | 271 | $3.07B |
| Q3 2021 | 248 | $2.85B |
| Q2 2021 | 227 | $2.71B |
| Q1 2021 | 240 | $2.32B |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Prestige Consumer Healthcare Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sawtooth Solutions, LLC | 0 | $0 | 0.00% | −6,645−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −6,482−100.0% | Sold out |
| Lindenwold Advisors | 0 | $0 | 0.00% | −5,702−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −4,481−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −4,346−100.0% | Sold out |
| Bridgefront Capital, LLC | 0 | $0 | 0.00% | −4,297−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −4,161−100.0% | Sold out |
| Lloyd Advisory Services, LLC. | 0 | $0 | 0.00% | −3,963−100.0% | Sold out |
| Okabena Investment Services Inc | 0 | $0 | 0.00% | −48−100.0% | Sold out |
| JJJ Advisors Inc. | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| Brown Brothers Harriman & Co | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Manchester Capital Management LLC | 0 | $0 | 0.00% | −17−100.0% | Sold out |
| Tfo-TDC, LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| First Republic Investment Management, Inc. | – | – | – | – | Not filed |
| Advisor Partners II, LLC | – | – | – | – | Not filed |
| Steward Financial Group LLC | – | – | – | – | Not filed |